PHKA2 Inhibitors
PHKA2 inhibitors, as understood from the chemicals identified, primarily aim to modulate the associated glycogen metabolism pathway, in which PHKA2 is pivotal. A major route to indirectly modulate PHKA2 is through the alteration of AMPK activities. Another significant pathway linked to glycogen metabolism involves PI3K. Wortmannin and LY294002 are PI3K inhibitors. By targeting PI3K, these chemicals exert influence on glycogen synthesis, thereby having indirect effects on PHKA2.
Furthermore, the integrity of pancreatic beta-cells and insulin's functionality are paramount to glycogen metabolism. Chemicals such as Alloxan and Streptozotocin impair beta-cell function, influencing insulin secretion. Altered insulin action, as a result, can have cascading effects on glycogen synthesis and, by extension, on PHKA2. Additionally, mTOR, a central regulator of cellular growth and metabolism, plays a role in glycogen synthesis. Rapamycin's inhibitory action on mTOR provides another route to indirectly influence PHKA2. Meanwhile, agents such as Palmitate and Rosiglitazone act on insulin sensitivity and signaling, offering another layer of modulation on glycogen synthesis and on PHKA2. Lastly, Chloroquine and 2-DG, through their unique actions on cellular processes, can indirectly affect the broader spectrum
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $96.00 $355.00 | 69 | |
AMPK inhibitor. By inhibiting AMPK, it can influence the glycogen synthesis pathway, thereby indirectly affecting PHKA2. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor. PI3K influences glycogen synthesis, and by inhibiting it, there might be an indirect effect on PHKA2. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor like Wortmannin. By impacting the PI3K pathway, it might indirectly influence PHKA2. | ||||||
Alloxan monohydrate | 2244-11-3 | sc-254940 | 10 g | $54.00 | ||
Generates ROS that impair beta-cell function affecting insulin secretion and thereby, glycogen synthesis and potentially PHKA2. | ||||||
Streptozotocin (U-9889) | 18883-66-4 | sc-200719 sc-200719A | 1 g 5 g | $116.00 $530.00 | 152 | |
Alkylates DNA, damaging pancreatic beta-cells which affects insulin production and thereby glycogen metabolism and possibly PHKA2. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor. mTOR can regulate glycogen synthesis, and by inhibiting it, there might be an indirect effect on PHKA2. | ||||||
Palmitic Acid | 57-10-3 | sc-203175 sc-203175A | 25 g 100 g | $114.00 $286.00 | 2 | |
Promotes insulin resistance, affecting insulin signaling. By modulating insulin's action, it can indirectly influence PHKA2. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPAR-γ agonist influencing insulin sensitivity and thereby glycogen synthesis, which might indirectly modulate PHKA2. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
Glucose analog that inhibits glycolysis and impacts glucose metabolism, potentially influencing glycogen synthesis and PHKA2. | ||||||